Viewing Study NCT03298867


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2025-12-25 @ 11:10 PM
Study NCT ID: NCT03298867
Status: COMPLETED
Last Update Posted: 2024-07-11
First Post: 2017-09-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Sponsor: Amgen
Organization: